Industry domain insight

How AI Is Used in Pharma IT & Security

This view tracks 6 documented AI deployments. Drug discovery is the most common use-case type with 2 cases.

Executive brief

The most common AI use-case type here is Drug discovery, with 2 source-linked cases, 1 in the last 6 months.

Cases

6

2 in the last 6 months

Innovativeness

3.4Differentiated

100% of evidence scored

Cases trend

Cases 1Agent 0

Early signal: Drug discovery — a promising impact-for-effort profile in limited evidence (2 cases).

Relative leverage

Which use-case types show the strongest leverage?

No type clears the higher-leverage threshold among the 1 scored type shown; Drug discovery (2 cases) is the largest high-impact investment signal.

Peer-relative view1 scored type shownMedian impact 4.2 · effort 3.8
Relative position:Higher leverageHigh-impact investmentsEfficient extensionsReview trade-offsDot size = scored casesTrending (last 6 months)
Higher leverage: Above-median impact with at-or-below-median effort among the types shown.HIGHER LEVERAGEHigh-impact investments: Above-median impact and effort among the types shown.STRATEGIC BETSEfficient extensions: At-or-below-median impact and effort among the types shown.EFFICIENT EXTENSIONSReview trade-offs: At-or-below-median impact with above-median effort among the types shown.REVIEW TRADE-OFFSHigher relative impact ↑Higher relative effort →Relative impact

Use-case types

Tap a type to open

  1. 1

    Drug discovery

    High-impact investments · 2 cases · 2 scored

    Directional evidence

    Impact
    Effort
ⓘ How to read this chart

Each dot is one Pharma IT & Security use-case type, sitting at the mean build effort and business impact of its scored cases, positioned relative to the other scored types shown. The dashed crosshair is the peer median, so the split compares leverage within this view.

The dashed indigo zone marks higher leverage: above-median impact for at-or-below-median effort. Dot size reflects scored cases; impact and effort figures in the list are the true 1–5 averages.

Implementation

Do teams build, buy, or compose this?

How the documented deployments in this view were built — custom engineering (Build), an off-the-shelf assistant (Buy), or low-code assembly (Compose).

2 classified cases
BuildBuyComposeMixed

2 of 6 cases classified (33%) · Compare all use-case types

Full report

Expand any section for the detail behind the summary above.

Most-reported outcome themes: Speed & agility (5 cases), New product / capability (4 cases), Risk & compliance (4 cases), and Employee experience (3 cases). Expand for the per-type breakdown.

Reported challenge examples: Algorithm bias leading to asymmetric treatment protocols (1 case), Build and operationalize AI and machine learning capabilities quickly in a complex global pharmaceutical organization (1 case), Clinical data silos slowed down research and the ability to answer complex medical questions promptly (1 case), Cybersecurity became a growing concern with digital transformation (1 case), and Data privacy and cybersecurity concerns when deploying AI (1 case). Evidence is still limited; expand to inspect the source cases.

Adoption pulse: 2 of the 6 cases in this view were published in the last 6 months. Expand for the adoption curve.

Questions answered here:

  • What are the most common AI use cases in Pharma IT & Security?

Related Insights

Next steps

Keep following this view or inspect the underlying case table.